163
Views
1
CrossRef citations to date
0
Altmetric
Articles

The Influence of Chemokine CXCR4 and Cyclooxygenase-2 in the Recurrence of Pterygium

, MD, , MD, , MD, , MD & , MD
Pages 328-332 | Received 05 Jul 2015, Accepted 02 Nov 2015, Published online: 22 Feb 2016
 

ABSTRACT

Purpose: To investigate the role of CXCR4 and cyclooxygenase-2 in pterygium recurrence.

Methods: A total of 18 primary and 9 recurrent pterygium samples were analyzed. Immunohistochemical staining using primary antibodies against cyclooxygenase-2 and CXCR4 was performed. The cyclooxygenase-2 and CXCR4 expressing cells were calculated separately on the epithelium and stroma. In addition, a correlation between the area of pterygium and CXCR4 and cyclooxygenase-2 levels was investigated.

Results: In the primary pterygium group, cyclooxygenase-2 staining was more intense in the epithelium and more dominant in the stroma of the recurrence samples. The CXCR4 expression was more intense in the stroma of both groups. The highest CXCR4 expression was observed in the recurrent pterygium group. There was a strong correlation between the area of pterygium and CXCR4 and cyclooxygenase-2 of stroma.

Conclusions: CXCR4 and cyclooxygenase-2 may play an important role in the recurrence of pterygium.

DECLARATION OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.